Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2008, Vol. 112, No. 3, pp. 912-913.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, H. P. H.
Right arrow Articles by Hogg, P. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Liang, H. P. H.
Right arrow Articles by Hogg, P. J.
Related Collections
Right arrowRelated Articles in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

Critical importance of the cell system when studying tissue factor de-encryption

To the editor:

Mammalian blood coagulation is triggered when factor VIIa binds productively to tissue factor (TF). TF resides on the cell surface in a cryptic configuration that can rapidly transform into an active configuration upon disruption of the cell. We have suggested that the disulfide bond in the membrane proximal domain (Cys186-Cys209) of TF is involved in de-encryption.1 This bond has an –RHStaple configuration, which is a feature of allosteric disulfides.2

Several observations support a mechanism where the bond is broken in the cryptic form of the protein and activation involves formation of the disulfide.1,35 For example, the thiol-alkylating agent, methyl methanethiolsulfonate (MMTS), blocks TF activation and the thiol-oxidising agent, HgCl2, promotes activation.

This proposal was recently questioned by Pendurthie et al.6 These investigators used the human breast carcinoma cell line MDA-MB231 to study TF de-encryption. In this letter we compare and contrast TF de-encryption in MDA-MB231 cells with 3 other human monocytic cell types. Myeloid leukemia HL60 cells7 and monocytic U937 cells8 were differentiated with phorbol myristate acetate (PMA), which also triggers TF expression.9 PMA treatment did not change TF expression in monocytic THP1 cells.

Brief (30 seconds) exposure to ionomycin or HgCl2 resulted in an 18- to 29-fold increase in TF procoagulant activity in HL60, U937, and THP1 cells (Figure 1A). Preincubation of the cells with MMTS reduced TF activation by ionomycin or HgCl2 by at least 83% in all 3 monocytic cells (Figure 1A). In contrast to the results with these monocytic cell lines, TF activity in MDA-MB231 cells was not influenced by ionomycin or HgCl2 treatment (Figure 1A). Preincubation with MMTS also had no effect on TF activity. Procoagulant activity on all cell types was ablated with 10 µg/mL of the anti-TF antibody 9C3 but not 10H10, which blocks TF signaling but not coagulation3 (data not shown).


Figure 1
View larger version (18K):
[in this window]
[in a new window]

 
Figure 1. Comparison of TF de-encryption in different cell types. (A) HL60 and U937 cells were stimulated for 6 hours with 1 µM PMA to induce TF expression. The PMA-treated cell lines and THP1 and MDA-MB231 cells were incubated with 10 µM ionomycin (IM), 100 µM HgCl2 (Hg) or dimethylsulfoxide vehicle control for 30 seconds and TF procoagulant activity measured by clotting time or by analysis of progress curves of factor X activation.1 Both methods of measuring TF procoagulant activity gave equivalent results (data not shown). Cells were also preincubated for 10 minutes with 10 mM (HL60, U937, and MDA-MB231 cells) or 50 mM (THP1 cells) MMTS before the addition of ionomycin or HgCl2. Results are expressed as fold change in TF activity compared with DMSO-treated cells. The bars and errors are the means plus or minus the SE of at least 3 determinations. (B) MDA-MB231 cells at approximately 80% confluence were incubated with 50 mM GSH or DTT or 10 mM MMTS for 15 minutes at 37°C and the cells washed twice with HEPES-buffered saline. Cell viability was determined using CytoTox-One Reagent (Promega, Madison, WI). The bars and errors are the means plus or minus the SE of 3 determinations.

 
Pendurthie et al6 observed an approximately 4-fold increase in TF activity in MDA-MB231 cells when exposed to 100 µM HgCl2 for 15 minutes, 30 times the period of incubation used herein. This relatively modest increase in TF activity is likely due to change in phosphatidylserine exposure, as suggested by the authors. TF de-encryption on HL60 cells could not be explained by this mechanism.1

Pendurthie et al6 also observed an increase in TF activity in MDA-MB231, endothelial, and fibroblast cells after 15 minutes treatment with 20 to 100 mM reduced glutathione (GSH) and dithiothreitol (DTT), and interpreted this result as evidence against the involvement of the Cys186-Cys209 disulfide in TF de-encryption.6 The GSH and DTT effect may be related to the cytotoxicity of these compounds at the concentrations used. GSH or DTT at 50 mM killed 31% and 35% of MDA-MB231 cells, respectively, under the conditions used by Pendurthie et al (Figure 1B). MMTS at 10 mM, on the other hand, had no significant effect on cell viability.

It is apparent from these results that although MDA-MB231 cells express abundant TF, it appears to be constitutively active. This cell line, therefore, is not suitable for the study of TF de-encryption.

Authorship

Contribution: H.P.H.L. performed the experiments and analyzed the data described in the letter. P.J.H. designed the experiments and wrote the letter.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Correspondence: Philip J. Hogg, UNSW Cancer Research Centre, University of New South Wales, Sydney 2052, Australia; e-mail: p.hogg{at}unsw.edu.au.

Hai Po Helena Liang, and Philip J. Hogg

References

  1. Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, Hogg PJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry. 2006;45:12020–12028.[CrossRef][Medline] [Order article via Infotrieve]

  2. Schmidt B, Ho L, Hogg PJ. Allosteric disulfide bonds. Biochemistry. 2006;45:7429–7433.[CrossRef][Medline] [Order article via Infotrieve]

  3. Ahamed J, Versteeg HH, Kerver M, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A. 2006;103:13932–13937.[Abstract/Free Full Text]

  4. Chen VM, Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost. 2006;4:2533–2541.[CrossRef][Medline] [Order article via Infotrieve]

  5. Reinhardt C, von Bruhl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest. 2008;118:1110–1122.[Medline] [Order article via Infotrieve]

  6. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood. 2007;110:3900–3908.[Abstract/Free Full Text]

  7. Rovera G, Santoli D, Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A. 1979;76:2779–2783.[Abstract/Free Full Text]

  8. Koren HS, Anderson SJ, Larrick JW. In vitro activation of a human macrophage-like cell line. Nature. 1979;279:328–331.[CrossRef][Medline] [Order article via Infotrieve]

  9. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89:3270–3276.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles in Blood Online:

Response: Tissue factor de-encryption: the cell model system
Usha R. Pendurthi and L. Vijaya Mohan Rao
Blood 2008 112: 913. [Full Text] [PDF]

Encryption remains cryptic
James H. Morrissey
Blood 2007 110: 3822-3823. [Full Text] [PDF]

Tissue factor activation: is disulfide bond switching a regulatory mechanism?
Usha R. Pendurthi, Samit Ghosh, Samir K. Mandal, and L. Vijaya Mohan Rao
Blood 2007 110: 3900-3908. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, H. P. H.
Right arrow Articles by Hogg, P. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Liang, H. P. H.
Right arrow Articles by Hogg, P. J.
Related Collections
Right arrowRelated Articles in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020